Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Biotechnology
Get the latest updates from GlobeNewswire - Industry News on Biotechnology directly as they happen.
Follow now 79 followers
Latest posts
Last updated about 5 hours ago
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
about 5 hours ago
BURLINGTON, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria”...
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
about 5 hours ago
Myriad Genetics will hold its third quarter 2025 earnings conference call at...
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
about 5 hours ago
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today...
Arcutis to Present at Upcoming Investor Conferences
about 5 hours ago
Arcutis today announced that management will participate in two upcoming investor conferences...
Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration
about 8 hours ago
Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor...
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
about 8 hours ago
Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris...
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe
about 8 hours ago
Saint-Herblain (France), le 27 octobre 2025 – Valneva SE (Nasdaq: VALN; Euronext...
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
about 10 hours ago
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical...
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
about 12 hours ago
Dr. Joshua Hare, CSO and Exec Chairman interviewed on NPR's BioTech Nation...
Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development
about 13 hours ago
Pioneering Precision Engineering to Transform Global Therapeutics Delivery Pioneering Precision Engineering to...
INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute
about 13 hours ago
MIDDLETON, Wis. and SARASOTA, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- INVO...
ORIC® Pharmaceuticals Presented Preclinical Data at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics Supporting Best-in-Class Potential of ORIC-944 to Treat Patients With Prostate Cancer and Other Solid Tumors
about 13 hours ago
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE)...